Mark T Iwicki Insider Trading $SEPR Sunovion Pharmaceuticals Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Mark T Iwicki.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Mark T Iwicki. Mark T Iwicki is EVP & Chief Commercial Officer in Sunovion Pharmaceuticals Inc. ($SEPR) and Chief Executive Officer in Kala Pharmaceuticals, Inc. ($KALA) and Director in Pulmatrix, Inc. ($PULM) and Director in Aimmune Therapeutics, Inc. ($AIMT) and Director in Akero Therapeutics, Inc. ($AKRO).
Mark T Iwicki in Sunovion Pharmaceuticals Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Mark T Iwicki: EVP & Chief Commercial Officer
Holdings: 0 shares
Latest Transaction: Oct 22 2009
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Mark T Iwicki in Sunovion Pharmaceuticals Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AIMT, AKRO, KALA, PULM, SEPR
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 22 2009 | SEPR | Sunovion Pharmaceu ... | Iwicki Mark T | EVP & Chief Commerc ... | Option Exercise | D | 14.40 | 57,500 | 828,000 | 0 | |
| Oct 22 2009 | SEPR | Sunovion Pharmaceu ... | Iwicki Mark T | EVP & Chief Commerc ... | Option Exercise | D | 21.26 | 42,165 | 896,428 | 0 | |
| Oct 22 2009 | SEPR | Sunovion Pharmaceu ... | Iwicki Mark T | EVP & Chief Commerc ... | Sell | D | 23.00 | 122,334 | 2,813,682 | 0 | 122.3 K to 0 (-100.00 %) |
| Oct 19 2009 | SEPR | Sunovion Pharmaceu ... | Iwicki Mark T | EVP & Chief Commerc ... | Sell | U | 23.00 | 27,666 | 636,318 | 122,334 | 150 K to 122.3 K (-18.44 %) |
| May 14 2009 | SEPR | Sunovion Pharmaceu ... | Iwicki Mark T | EVP & Chief Commerc ... | Option Exercise | A | 14.40 | 57,500 | 828,000 | 57,500 | |
| May 14 2009 | SEPR | Sunovion Pharmaceu ... | Iwicki Mark T | EVP & Chief Commerc ... | Grant | A | 14.40 | 35,000 | 504,000 | 150,000 | 115 K to 150 K (+30.43 %) |
| May 22 2008 | SEPR | Sunovion Pharmaceu ... | Iwicki Mark T | EVP & Chief Commerc ... | Option Exercise | A | 21.26 | 42,165 | 896,428 | 42,165 | |
| May 22 2008 | SEPR | Sunovion Pharmaceu ... | Iwicki Mark T | EVP & Chief Commerc ... | Grant | A | 21.26 | 35,000 | 744,100 | 115,000 | 80 K to 115 K (+43.75 %) |
| Oct 22 2007 | SEPR | Sunovion Pharmaceu ... | Iwicki Mark T | EVP & Chief Commerc ... | Option Exercise | A | 24.89 | 150,000 | 3,733,500 | 150,000 | |
| Oct 22 2007 | SEPR | Sunovion Pharmaceu ... | Iwicki Mark T | EVP & Chief Commerc ... | Grant | A | 24.89 | 80,000 | 1,991,200 | 80,000 | 0 to 80 K |
Page: 1